Blood Pressure Effects of Strattera

Clinical Monitoring and Management

• The International Society of Hypertension recommends screening all patients with hypertension or at risk for hypertension for medications that may increase blood pressure, including sympathomimetics like atomoxetine, with a strength of evidence based on clinical guidelines 1, 2
• The International Society of Hypertension guidelines include sympathomimetics as a category that increases blood pressure, which is relevant to the use of atomoxetine, a selective norepinephrine reuptake inhibitor 1, 2
• If atomoxetine is required in a patient with hypertension, blood pressure should be treated to target regardless, but the medication should be avoided entirely in patients with uncontrolled hypertension or severe cardiovascular disease, according to the International Society of Hypertension guidelines 1, 2